rs2486668
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000361548.9(GRHL3):āc.165C>Gā(p.Asp55Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 1,613,514 control chromosomes in the GnomAD database, including 23,185 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000361548.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRHL3 | NM_198173.3 | c.165C>G | p.Asp55Glu | missense_variant | 2/16 | ENST00000361548.9 | NP_937816.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRHL3 | ENST00000361548.9 | c.165C>G | p.Asp55Glu | missense_variant | 2/16 | 1 | NM_198173.3 | ENSP00000354943 | P1 |
Frequencies
GnomAD3 genomes AF: 0.170 AC: 25869AN: 152002Hom.: 2314 Cov.: 32
GnomAD3 exomes AF: 0.158 AC: 39675AN: 251202Hom.: 3333 AF XY: 0.155 AC XY: 21071AN XY: 135782
GnomAD4 exome AF: 0.167 AC: 243937AN: 1461394Hom.: 20866 Cov.: 32 AF XY: 0.165 AC XY: 120267AN XY: 727028
GnomAD4 genome AF: 0.170 AC: 25883AN: 152120Hom.: 2319 Cov.: 32 AF XY: 0.166 AC XY: 12371AN XY: 74370
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 18, 2020 | This variant is associated with the following publications: (PMID: 31332962) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 08, 2021 | The p.Asp55Glu variant in GRHL3 is classified as benign because it has been identified in 15.97% (4526/282536) of total chromosomes in gnomAD, including 3777 homozygous individuals (http://gnomad.broadinstitute.org). ACMG/AMP criteria applied: BA1. - |
Van der Woude syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at